EDAP TMS S.A.: Business Overview, Financials & Competitive Analysis
EDAP TMS S.A. is a medical technology company that develops, manufactures, markets, and sells non-invasive therapeutic ultrasound and energy-based medical devices. The company operates through three divisions: HIFU (H...
Cyborg Score thesis
High-growth HIFU business momentum offset by cash burn and path to profitability uncertainty....
Read the full analyst-debate transcript →Get the Latest EDAP TMS S.A. Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeEDAP TMS S.A. Overview
Pro stress-test →EDAP TMS S.A. is a medical technology company that develops, manufactures, markets, and sells non-invasive therapeutic ultrasound and energy-based medical devices. The company operates through three divisions: HIFU (High-Intensity Focused Ultrasound) for invasive destruction of tumors, ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution.
Strategic Profile
Pro stress-test →EDAP markets HIFU devices including the Ablatherm, Ablatherm Fusion, and Focal One, while operating a manufacturing and service business for its Sonolith range of lithotripters. The company is shifting strategic focus toward high-margin HIFU products, particularly the Focal One robotic system for prostate cancer treatment, while de-emphasizing legacy ESWL and distribution businesses.
Competitive Landscape
Pro stress-test →Siemens Healthineers is identified as a competitor. The HIFU ultrasound and energy-based medical device market includes manufacturers of competitive ablation technologies and prostate cancer treatment systems. EDAP differentiates through its proprietary robotic Focal One platform and expanding clinical evidence for prostate cancer indications.
Industry Context
EDAP TMS S.A. operates in Medical Devices - Ultrasound & Energy-Based Therapeutics.
Key facts
Founded: 1979 · Headquarters: Vaulx-en-Velin, France · Revenue: $70.5M · Market cap: $127M